Leitlinienreport zur aktualisierten S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) zur Prävention, Diagnostik und Behandlung von Gallensteinen

1. Hintergrund der Leitlinie

Die Entwicklung und Implementierung von nationalen, hochwertigen evidenz- und konsensbasierten Leitlinien ist eine wesentliche Grundlage für eine optimierte und sichere Versorgung unserer Patienten. 15 – 20 % unserer Bevölkerung haben Gallensteine [1] [2] [3] [4], und jährlich werden in Deutschland mehr als 175 000 Cholezystektomien aufgrund einer Cholelithiasis durchgeführt [5] [6]. Das Gallensteinleiden ist damit nach der Refluxerkrankung die gastroenterologische Erkrankung, die die höchsten Kosten verursacht [7]. Folgerichtig wurde bereits 2000 eine erste Leitlinie publiziert, um eine evidenzbasierte und einheitliche Behandlung des Gallensteinleidens zu gewährleisten. 2007 erfolgte eine erste Aktualisierung auf S3-Niveau, deren Gültigkeit 2012 endete. Inzwischen wurden weitere wichtige Leitlinien, Metaanalysen und randomisierte Studien veröffentlicht, die eine erneute Überarbeitung der Leitlinie erforderten.

Die Leitlinie zur Prävention, Diagnostik und Therapie dieser sehr häufigen Erkrankung wurde von der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) gemeinsam entwickelt. Die bisherigen Leitlinien, die auf die Diagnostik und die Therapie fokussierten, wurden hierbei auch um Empfehlungen zur Prävention des Gallensteinleidens erweitert.

Die Leitlinie ist eine systematisch entwickelte ärztliche Orientierungshilfe mit Handlungs- und Entscheidungsvorschlägen, von denen in begründeten Fällen abgewichen werden kann oder sogar muss. Die Entscheidung, ob einer bestimmten Empfehlung gefolgt wird, trifft der behandelnde Arzt unter Berücksichtigung der individuellen Situation seines Patienten.

1.1 Zielorientierung der Leitlinie

Ziel ist es, die neuen Erkenntnisse zur Definition, Epidemiologie und Resistenzlage sowie Fortschritte in der Diagnostik und Therapie zu bewerten und zu integrieren. Zu Beginn dieser vollständigen Leitlinienaktualisierung wurde daher zunächst der Überarbeitungsbedarf der Leitlinie in folgenden Schritten analysiert und festgelegt.

Festlegung des inhaltlichen Überarbeitungsbedarfs:

• Orientierende Literaturrecherche insbesondere nach Quellen aggregierter Evidenz

• Aufarbeitung der Kommentare und Korrekturvorschläge zur alten Leitlinie

• Expertenbefragung der Leitliniengruppe zum Änderungs- und Ergänzungsbedarf

• Priorisierung des Überarbeitungsbedarfs der alten Leitlinienempfehlung, Festlegung der Evidenzgrundlage und Ergänzung neuer Schlüsselfragen

• Konsentierung durch die Steuergruppe (Koordinator, AG-Leiter und Mandatsträger der eingeladenen Fachgesellschaften)

Dem Entwicklungsprozess lagen wie auch bei den Vorgängerversionen die Anforderungen des Deutschen Instruments zur methodischen Leitlinien-Bewertung (DELBI) zugrunde [8]. Die Methodik der Leitlinie beruht auf dem zurzeit gültigen Regelwerk der AWMF, dem Cochrane Manual Systematische Literaturrecherche für die Erstellung von Leitlinien und dem Leitlinienprogramm der DGVS [9] [10] [11], hierbei ergaben sich einige Änderungen, insbesondere in der Darstellung der angewandten Methodik.

Festlegung des methodischen Überarbeitungsbedarfs:

1. Systematische Literaturrecherche ab 2007, Auswahl und Bewertung der Literatur für prioritäre Fragestellungen

2. Klassifizierung von Studien und Empfehlungen nach den Kriterien der evidenzbasierten Medizin, Erstellen von Evidenztabellen

3. Dokumentation der Evidenzrecherche (Suchstrategien, Trefferquoten, Auswahl der Evidenz und Dokumentation der Ausschlussgründe)

4. Änderung der Empfehlungsgraduierung nach A („soll“), B („sollte“) und 0 („kann“)

5. Formulierung von Qualitätszielen für die Versorgung

6. Dokumentation und Bewertung potenzieller Interessenskonflikte im Leitlinienreport, Offenlegung im Leitlinienreport

 

MissingLinkText

1.2 Patientenzielgruppe

Die Leitlinie richtet sich an Erwachsene mit Gallensteinen sowie deren Folgekrankheiten.

 

MissingLinkText

1.3 Versorgungsbereich

Die Leitlinie gilt sowohl für die ambulante als auch die stationäre medizinische Versorgung und behandelt Prävention, Diagnostik und Therapie in der primärärztlichen und der spezialfachärztlichen Versorgung.

 

MissingLinkText

1.4 Anwenderzielgruppe

Die Leitlinie richtet sich insbesondere an alle an der Beratung, Diagnostik und Therapie der Erkrankung beteiligten Internisten, Gastroenterologen und Chirurgen. Sie soll darüber hinaus aber andere Institutionen und Organisationen wie zum Beispiel Medizinisch-Wissenschaftlichen Fachgesellschaften und Berufsverbänden, Interessenvertretungen der Patienten, Gesundheitspolitischen Einrichtungen und Entscheidungsträgern, Kostenträgern sowie der Öffentlichkeit zur Information über gute medizinische Vorgehensweise dienen.

 

MissingLinkText

• Literatur

• 1 Berndt H, Nürnberg D, Pannwitz H. Prävalenz der Cholelithiasis. Ergebnisse einer epidemiologischen Studie mittels Sonographie in der DDR. Z Gastroenterol 1989; 27: 662-666
• 2 Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 1999; 27: 1-7
• 3 Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 423-433
• 4 Völzke H, Baumeister SE, Alte D. et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005; 71: 97-105
• 5 Spindler J. Fallpauschalenbezogene Krankenhausstatistik: Diagnosen und Prozeduren der Krankenhauspatienten auf Basis der Daten nach §21 Krankenhausentgeltgesetz. In: Klauber J, Geraedts M, Friedrich J eds. et al. Hrsg Krankenhaus-Report 2017 Schwerpunkt: Zukunft gestalten. Stuttgart: Schattauer; 2017: 321-353
• 6 Wittenburg H. Pathoegnese der Gallensteine. Gastroenterologe 2018; 13: 6-14
• 7 Sandler RS, Everhart JE, Donowitz M. et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-1511
• 8 Encke A, Kopp I, Selbmann HK. et al. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Ärztliches Zentrum für Qualität in der Medizin (ÄZQ), and (Hrsg). Deutsches Instrument zur methodischen Bewertung von Leitlinien: DELBI. DtÄrztebl■. 102. A1912-A1913 www.delbi.de
• 9 Lynen JansenP, Preiss JC, Muche-Borowski C. et al. Das Leitlinienprogramm der DGVS. Z Gastroenterol 2013; 51: 643-650
• 10 Muche BorowskiM. http://www.awmf.org/leitlinien/awmf-regelwerk/awmf-regelwerk-offline.html
• 11 Gechter D. et al. http://www.cochrane.de/sites/cochrane.de/files/uploads/20130523_Manual_Literaturrecherche_Final.pdfGechter
• 12 Neubrand M, Sackmann M, Caspary WF. et al. Guidelines by the German Society of Digestive and Metabolic Diseases for treatment of gallstones. German Society of Digestive and Metabolic Diseases. Z Gastroenterol 2000; 38: 449-468
• 13 Lammert F, Neubrand MW, Bittner R. et al. S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten und der Deutschen Gesellschaft für Viszeralchirurgie zur Diagnostik und Behandlung von Gallensteinen. Z Gastroenterol 2007; 45: 971-1001
• 14 Takada T, Strasberg SM, Solomkin JS. et al. TG13: updated Tokyo guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013; 20: 1-7
• 15 Warttig S, Ward S, Rogers G. et al. Diagnosis and management of gallstone disease: summary of NICE guidance. BMJ 2014; 349: g6241
• 16 Neederlandse richtlijnGalsteenlijden. 2016 https://richtlijnendatabase.nl/richtlijn/galsteenlijden/galsteenlijden_-_startpagina.html
• 17 European Association for theStudy of the Liver. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol 2016; 65: 146-181
• 18 Williams E, Beckingham I, El SayedG. et al. Updated guideline on the management of common bile duct stones (CBDS). Gut 2017; 66: 765-782
• 19 da Costa DW, Bouwense SA, Schepers NJ. et al. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet 2015; 386: 1261-1268
• 20 Medizinischer Fakultätentag. Nationaler Kompetenzbasierter Lernzielkatalog Medizin (NKLM) 2015. Berlin: 2015
• 21 Leese T, Neoptolemos JP, Baker AR. et al. Management of acute cholangitis and the impact of endoscopic sphincterotomy. Br J Surg 1986; 73: 988-992
• 22 Lai EC, Mok FP, Tan ES. et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992; 326: 1582-1586
• 23 Leung JW, Ling TK, Chan RC. et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994; 40: 716-721
• 24 Sharma BC, Agarwal DK, Baijal SS. et al. Endoscopic management of acute calculous cholangitis. J Gastroenterol Hepatol 1997; 12: 874-876
• 25 Csendes A, Diaz JC, Burdiles P. et al. Risk factors and classification of acute suppurative cholangitis. Br J Surg 1992; 79: 655-658
• 26 Boey JH, Way LW. Acute cholangitis. Ann Surg 1980; 191: 264-270
• 27 Reynolds BM, Dargan EL. Acute obstructive cholangitis; a distinct clinical syndrome. Ann Surg 1959; 150: 299-303
• 28 Shea JA, Berlin JA, Escarce JJ. et al. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med 1994; 154: 2573-2581
• 29 Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have acute cholecystitis?. JAMA 2003; 289: 80-86
• 30 Tenner S, Dubner H, Steinberg W. Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis. Am J Gastroenterol 1994; 89: 1863-1866
• 31 Ammori BJ, Boreham B, Lewis P. et al. The biochemical detection of biliary etiology of acute pancreatitis on admission: a revisit in the modern era of biliary imaging. Pancreas 2003; 26: e32-35
• 32 Lévy P, Boruchowicz A, Hastier P. et al. Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients. Pancreatology 2005; 5: 450-456
• 33 Liu CL, Fan ST, Lo CM. et al. Clinico-biochemical prediction of biliary cause of acute pancreatitis in the era of endoscopic ultrasonography. Aliment Pharmacol Ther 2005; 22: 423-431
• 34 Sackmann M. Behandlung der biliären Kolik. Dtsch Med Wochenschr 1998; 123: 945-947
• 35 Festi D, Sottili S, Colecchia A. et al. Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology 1999; 30: 839-846
• 36 Neubrand M, Sackmann M, Caspary W. et al. Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zur Behandlung von Gallensteinen. Z Gastroenterol 2000; 38: 449-468
• 37 Lorenz W, Ollenschläger G, Geraedts M. et al. Das Leitlinien-Manual. Entwicklung und Implementierung von Leitlinien in der Medizin. Z Ärztl Fortbild Qual Gesundheitswes 2001; 95: 1-84
• 38 Beyer M, Geraedts M, Gerlach FM. et al. Deutsches Instrument zur methodischen Leitlinien-Bewertung (DELBI). Z Ärztl Fortbild Qual Gesundheitswes 2006; 99: 468-492
• 39 Rünzi M, Layer P, Büchler MW. et al. Therapie der akuten Pankreatitis. Gemeinsame Leitlinien. Z Gastroenterol 2000; 38: 571-581
• 40 Singer M, Deutschman CS, Seymour CW. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016; 315: 801-810
• 41 Misciagna G, Centonze S, Leoci C. et al. Diet, physical activity, and gallstones – a population-based, case-control study in southern Italy. Am J Clin Nutr 1999; 69: 120-126
• 42 Tsai CJ, Leitzmann MF, Willett WC. et al. Long-term intake of dietary fiber and decreased risk of cholecystectomy in women. Am J Gastroenterol 2004; 99: 1364-1370
• 43 Tsai CJ, Leitzmann MF, Willett WC. et al. Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men. Gut 2005; 54: 823-828
• 44 Tsai CJ, Leitzmann MF, Willett WC. et al. Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women. Gastroenterology 2005; 129: 105-112
• 45 Tsai CJ, Leitzmann MF, Willett WC. et al. Fruit and vegetable consumption and risk of cholecystectomy in women. Am J Med 2006; 119: 760-767
• 46 Nordenvall C, Oskarsson V, Wolk A. Fruit and vegetable consumption and risk of cholecystectomy: a prospective cohort study of women and men. Eur J Nutr 2018; 57: 75-81
• 47 Pixley F, Wilson D, McPherson K. et al. Effect of vegetarianism on development of gall stones in women. Br Med J (Clin Res Ed) 1985; 291: 11-12
• 48 Pixley F, Mann J. Dietary factors in the aetiology of gall stones: a case control study. Gut 1988; 29: 1511-1515
• 49 Walcher T, Haenle MM, Mason RA. et al. The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence. Eur J Gastroenterol Hepatol 2010; 22: 1345-1351
• 50 Lander EM, Wertheim BC, Koch SM. et al. Vegetable protein intake is associated with lower gallbladder disease risk: Findings from the Women's Health Initiative prospective cohort. Prev Med 2016; 88: 20-26
• 51 Barre A, Gusto G, Cadeau C. et al. Diet and risk of cholecystectomy: a prospective study based on the French E3N cohort. Am J Gastroenterol 2017; 112: 1448-1456
• 52 McConnell TJ, Appleby PN, Key TJ. Vegetarian diet as a risk factor for symptomatic gallstone disease. Eur J Clin Nutr 2017; 71: 731-735
• 53 Tsai CJ, Leitzmann MF, Hu FB. et al. Frequent nut consumption and decreased risk of cholecystectomy in women. Am J Clin Nutr 2004; 80: 76-81
• 54 Tsai CJ, Leitzmann MF, Willett WC. et al. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study. Ann Intern Med 2004; 141: 514-522
• 55 Tsai CJ, Leitzmann MF, Willett WC. et al. Long-term intake of trans-fatty acids and risk of gallstone disease in men. Arch Intern Med 2005; 165: 1011-1015
• 56 Tsai CJ, Leitzmann MF, Willett WC. et al. Long-chain saturated fatty acids consumption and risk of gallstone disease among men. Ann Surg 2008; 247: 95-103
• 57 Simon JA, Hudes ES. Serum ascorbic acid and other correlates of gallbladder disease among US adults. Am J Public Health 1998; 88: 1208-1212
• 58 Simon JA, Grady D, Snabes MC. et al. Ascorbic acid supplement use and the prevalence of gallbladder disease. Heart & Estrogen-Progestin Replacement Study (HERS) Research Group. J Clin Epidemiol 1998; 51: 257-265
• 59 Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III). Arch Intern Med 2000; 160: 931-936
• 60 Walcher T, Haenle MM, Kron M. et al. Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population. BMC Gastroenterol 2009; 9: 74
• 61 Tsai CJ, Leitzmann MF, Willett WC. et al. Long-term effect of magnesium consumption on the risk of symptomatic gallstone disease among men. Am J Gastroenterol 2008; 103: 375-382
• 62 Jørgensen T. Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut 1989; 30: 528-534
• 63 Misciagna G, Leoci C, Guerra V. et al. Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors. Eur J Gastroenterol Hepatol 1996; 8: 585-593
• 64 Leitzmann MF, Willett WC, Rimm EB. et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. Jama 1999; 281: 2106-2112
• 65 Ruhl CE, Everhart JE. Association of coffee consumption with gallbladder disease. Am J Epidemiol 2000; 152: 1034-1038
• 66 Leitzmann MF, Stampfer MJ, Willett WC. et al. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology 2002; 123: 1823-1830
• 67 Ishizuk H, Eguchi H, Oda T. et al. Relation of coffee, green tea, and caffeine intake to gallstone disease in middle-aged Japanese men. Eur J Epidemiol 2003; 18: 401-405
• 68 Nordenvall C, Oskarsson V, Wolk A. Inverse association between coffee consumption and risk of cholecystectomy in women but not in men. Clin Gastroenterol Hepatol 2015; 13: 1096-1102
• 69 Zhang YP, Li WQ, Sun YL. et al. Systematic review with meta-analysis: coffee consumption and the risk of gallstone disease. Aliment Pharmacol Ther 2015; 42: 637-648
• 70 Gebhard RL, Prigge WF, Ansel HJ. et al. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology 1996; 24: 544-548
• 71 Festi D, Colecchia A, Orsini M. et al. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes Relat Metab Disord 1998; 22: 592-600
• 72 Mendez-Sanchez N, Gonzalez V, Aguayo P. et al. Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight. J Nutr 2001; 131: 2300-2303
• 73 Moran S, Milke P, Rodriguez-Leal G. et al. Ref: Gallstone formation in obese subjects undergoing a weight reduction diet. Int J Obes Relat Metab Disord 1998; 22: 282-284
• 74 Utter AC, Whitcomb DC, Nieman DC. et al. Effects of exercise training on gallbladder function in an obese female population. Med Sci Sports Exerc 2000; 32: 41-45
• 75 Ko CW, Napolitano PG, Lee SP. et al. Physical activity, maternal metabolic measures, and the incidence of gallbladder sludge or stones during pregnancy: a randomized trial. Am J Perinatol 2014; 31: 39-48
• 76 Ahmed M, Diggory R. The correlation between ultrasonography and histology in the search for gallstones. Ann R Coll Surg Engl 2011; 93: 81-83
• 77 Ahvenjarvi L, Koivukangas V, Jartti A. et al. Diagnostic accuracy of computed tomography imaging of surgically treated acute acalculous cholecystitis in critically ill patients. J Trauma 2011; 70: 183-188
• 78 Altun E, Semelka RC, Elias J. et al. Acute cholecystitis: MR findings and differentiation from chronic cholecystitis. . Radiology 2007; 244: 174-183
• 79 Kiewiet JJ, Leeuwenburgh MM, Bipat S. et al. A systematic review and meta-analysis of diagnostic performance of imaging in acute cholecystitis. Radiology 2012; 264: 708-720
• 80 Gurusamy KS, Giljaca V, Takwoingi Y. et al. Ultrasound versus liver function tests for diagnosis of common bile duct stones. Cochrane Database Syst Rev 2015; 2: CD011548
• 81 Garrow D, Miller S, Sinha D. et al. Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction. Clin Gastroenterol Hepatol 2007; 5: 616-623
• 82 Jovanovic P, Salkic NN, Zerem E. et al. Biochemical and ultrasound parameters may help predict the need for therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in patients with a firm clinical and biochemical suspicion for choledocholithiasis. Eur J Intern Med 2011; 22: e110-e114
• 83 Karki S, Joshi KS, Regmi S. et al. Role of ultrasound as compared with ERCP in patient with obstructive jaundice. Kathmandu Univ Med J (KUMJ) 2013; 11: 237-240
• 84 Tse F, Liu L, Barkun AN. et al. EUS: a meta-analysis of test performance in suspected choledocholithiasis. Gastrointest Endosc 2008; 67: 235-244
• 85 Tseng CW, Chen CC, Chen TS. et al. Can computed tomography with coronal reconstruction improve the diagnosis of choledocholithiasis?. J Gastroenterol Hepatol 2008; 23: 1586-1589
• 86 Patel R, Ingle M, Choksi D. et al. Endoscopic ultrasonography can prevent unnecessary aiagnostic endoscopic retrograde cholangiopancreatography even in patients with high likelihood of choledocholithiasis and inconclusive ultrasonography: results of a prospective study. Clin Endosc 2017; 50: 592-597
• 87 Narvaez RiveraRM, Gonzalez GonzalezJA, Monreal RoblesR. et al. Accuracy of ASGE criteria for the prediction of choledocholithiasis. Rev Esp Enferm Dig 2016; 108: 309-314
• 88 Sharma R, Menachery J, Choudhary NS. et al. Routine endoscopic ultrasound in moderate and indeterminate risk patients of suspected choledocholithiasis to avoid unwarranted ERCP: A prospective randomized blinded study. Indian J Gastroenterol 2015; 34: 300-304
• 89 Giljaca V, Gurusamy KS, Takwoingi Y. et al. Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones. Cochrane Database Syst Rev 2015; 2: CD011549
• 90 De Castro VL, Moura EG, Chaves DM. et al. Endoscopic ultrasound versus magnetic resonance cholangiopancreatography in suspected choledocholithiasis: A systematic review. Endosc Ultrasound 2016; 5: 118-128
• 91 Chen W, Mo JJ, Lin L. et al. Diagnostic value of magnetic resonance cholangiopancreatography in choledocholithiasis. World J Gastroenterol 2015; 21: 3351-3360
• 92 Meeralam Y, Al-Shammari K, Yaghoobi M. Diagnostic accuracy of EUS compared with MRCP in detecting choledocholithiasis: a meta-analysis of diagnostic test accuracy in head-to-head studies. Gastrointest Endosc 2017; 86: 986-993
• 93 Smith I, Ramesh J, Kyanam KabirBaig KR. et al. Emerging role of endoscopic ultrasound in the diagnostic evaluation of idiopathic pancreatitis. Am J Med Sci 2015; 350: 229-234
• 94 Wilcox CM, Seay T, Kim H. et al. Prospective endoscopic ultrasound-based approach to the evaluation of idiopathic pancreatitis: causes, response to therapy, and long-term outcome. Am J Gastroenterol 2016; 111: 1339-1348
• 95 Mazeh H, Mizrahi I, Dior U. et al. Role of antibiotic therapy in mild acute calculus cholecystitis: a prospective randomized controlled trial. World J Surg 2012; 36: 1750-1759
• 96 Schmidt M, Sondenaa K, Vetrhus M. et al. A randomized controlled study of uncomplicated gallstone disease with a 14-year follow-up showed that operation was the preferred treatment. Dig Surg 2011; 28: 270-276
• 97 Festi D, Dormi A, Capodicasa S. et al. Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol 2008; 14: 5282-5289
• 98 Festi D, Reggiani ML, Attili AF. et al. Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. J Gastroenterol Hepatol 2010; 25: 719-724
• 99 Khan ZS, Livingston EH, Huerta S. Reassessing the need for prophylactic surgery in patients with porcelain gallbladder: case series and systematic review of the literature. Arch Surg 2011; 146: 1143-1147
• 100 Cha BH, Hwang JH, Lee SH. et al. Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladder. World J Gastroenterol 2011; 17: 2216-2222
• 101 Colecchia A, Larocca A, Scaioli E. et al. Natural history of small gallbladder polyps is benign: evidence from a clinical and pathogenetic study. Am J Gastroenterol 2009; 104: 624-629
• 102 French DG, Allen PD, Ellsmere JC. The diagnostic accuracy of transabdominal ultrasonography needs to be considered when managing gallbladder polyps. Surg Endosc 2013; 27: 4021-4025
• 103 Ito H, Hann LE, D'Angelica M. et al. Polypoid lesions of the gallbladder: diagnosis and followup. J Am Coll Surg 2009; 208: 570-575
• 104 Elmasry M, Lindop D, Dunne DF. et al. The risk of malignancy in ultrasound detected gallbladder polyps: A systematic review. Int J Surg 2016; 33: 28-35
• 105 Bhatt NR, Gillis A, Smoothey CO. et al. Evidence based management of polyps of the gall bladder: A systematic review of the risk factors of malignancy. Surgeon 2016; 14: 278-286
• 106 Wiles R, Varadpande M, Muly S. et al. Growth rate and malignant potential of small gallbladder polyps--systematic review of evidence. Surgeon 2014; 12: 221-226
• 107 Li VK, Pulido N, Martinez-Suartez P. et al. Symptomatic gallstones after sleeve gastrectomy. Surg Endosc 2009; 23: 2488-2492
• 108 Moon RC, Teixeira AF, DuCoin C. et al. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis 2014; 10: 64-68
• 109 Plecka OstlundM, Wenger U, Mattsson F. et al. Population-based study of the need for cholecystectomy after obesity surgery. Br J Surg 2012; 99: 864-869
• 110 Stokes CS, Gluud LL, Casper M. et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 2014; 12: 1090-1100
• 111 Tsirline VB, Keilani ZM, El DjouziS. et al. How frequently and when do patients undergo cholecystectomy after bariatric surgery?. Surg Obes Relat Dis 2014; 10: 313-321
• 112 Warschkow R, Tarantino I, Ukegjini K. et al. Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis. Obes Surg 2013; 23: 397-407
• 113 Gelbard R, Karamanos E, Teixeira PG. et al. Effect of delaying same-admission cholecystectomy on outcomes in patients with diabetes. Br J Surg 2014; 101: 74-78
• 114 Gul R, Dar RA, Sheikh RA. et al. Comparison of early and delayed laparoscopic cholecystectomy for acute cholecystitis: experience from a single center. N Am J Med Sci 2013; 5: 414-418
• 115 Gurusamy KS, Davidson C, Gluud C. et al. Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis. Cochrane Database Syst Rev 2013; 6: CD005440
• 116 Gutt CN, Encke J, Koninger J. et al. Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg 2013; 258: 385-393
• 117 de Mestral C, Rotstein OD, Laupacis A. et al. A population-based analysis of the clinical course of 10,304 patients with acute cholecystitis, discharged without cholecystectomy. J Trauma Acute Care Surg 2013; 74: 26-30
• 118 Macafee DA, Humes DJ, Bouliotis G. et al. Prospective randomized trial using cost-utility analysis of early versus delayed laparoscopic cholecystectomy for acute gallbladder disease. Br J Surg 2009; 96: 1031-1040
• 119 Regimbeau JM, Fuks D, Pautrat K. et al. Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial. JAMA 2014; 312: 145-154
• 120 Roulin D, Saadi A, Di Mare L. et al. Early versus delayed cholecystectomy for acute cholecystitis, are the 72 hours still the rule? A randomized trial. Ann Surg 2016; 264: 717-722
• 121 Schmidt M, Sondenaa K, Vetrhus M. et al. Long-term follow-up of a randomized controlled trial of observation versus surgery for acute cholecystitis: non-operative management is an option in some patients. Scand J Gastroenterol 2011; 46: 1257-1262
• 122 Yadav RP, Adhikary S, Agrawal CS. et al. A comparative study of early vs. delayed laparoscopic cholecystectomy in acute cholecystitis. Kathmandu Univ Med J (KUMJ) 2009; 7: 16-20
• 123 Deng YL, Xiong XZ, Zhou Y. et al. Selective histology of cholecystectomy specimens--is it justified?. J Surg Res 2015; 193: 196-201
• 124 Glauser PM, Strub D, Kaser SA. et al. Incidence, management, and outcome of incidental gallbladder carcinoma: analysis of the database of the Swiss association of laparoscopic and thoracoscopic surgery. Surg Endosc 2010; 24: 2281-2286
• 125 Götze TO, Paolucci V. Immediate re-resection of T1 incidental gallbladder carcinomas: a survival analysis of the German Registry. Surg Endosc 2008; 22: 2462-2465
• 126 Hari DM, Howard JH, Leung AM. et al. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?. HPB (Oxford) 2013; 15: 40-48
• 127 Lee SE, Jang JY, Lim CS. et al. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol 2011; 17: 174-180
• 128 Swank HA, Mulder IM, Hop WC. et al. Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: a systematic review. Surg Endosc 2013; 27: 4439-4448
• 129 Tantia O, Jain M, Khanna S. et al. Incidental carcinoma gall bladder during laparoscopic cholecystectomy for symptomatic gall stone disease. Surg Endosc 2009; 23: 2041-2046
• 130 van Vliet JL, van Gulik TM, Verbeek PC. Is it necessary to send gallbladder specimens for routine histopathological examination after cholecystectomy? The use of macroscopic examination. Dig Surg 2013; 30: 472-475
• 131 Yoon JH, Lee YJ, Kim SC. et al. What is the better choice for T1b gallbladder cancer: simple versus extended cholecystectomy. World J Surg 2014; 38: 3222-3227
• 132 You DD, Lee HG, Paik KY. et al. What is an adequate extent of resection for T1 gallbladder cancers?. Ann Surg 2008; 247: 835-838
• 133 Zhang WJ, Xu GF, Zou XP. et al. Incidental gallbladder carcinoma diagnosed during or after laparoscopic cholecystectomy. World J Surg 2009; 33: 2651-2656
• 134 Fuks D, Regimbeau JM, Le TreutYP. et al. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg 2011; 35: 1887-1897
• 135 Fuks D, Regimbeau JM, Pessaux P. et al. Is port-site resection necessary in the surgical management of gallbladder cancer?. J Visc Surg 2013; 150: 277-284
• 136 Götze TO, Paolucci V. Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry. Ann Surg 2008; 247: 104-108
• 137 Maker AV, Butte JM, Oxenberg J. et al. Is port site resection necessary in the surgical management of gallbladder cancer?. Ann Surg Oncol 2012; 19: 409-417
• 138 Gurusamy KS, Vaughan J, Ramamoorthy R. et al. Miniports versus standard ports for laparoscopic cholecystectomy. Cochrane Database Syst Rev 2013; 8: CD006804
• 139 Milas M, Devedija S, Trkulja V. Single incision versus standard multiport laparoscopic cholecystectomy: up-dated systematic review and meta-analysis of randomized trials. Surgeon 2014; 12: 271-289
• 140 Keizman D, Ish-Shalom M, Konikoff FM. The clinical significance of bile duct sludge: is it different from bile duct stones?. Surg Endosc 2007; 21: 769-773
• 141 Lee YS, Kang BK, Hwang IK. et al. Long-term outcomes of symptomatic gallbladder sludge. J Clin Gastroenterol 2015; 49: 594-598
• 142 Alvarez FA, de Santibanes M, Palavecino M. et al. Impact of routine intraoperative cholangiography during laparoscopic cholecystectomy on bile duct injury. Br J Surg 2014; 101: 677-684
• 143 de Reuver PR, Rauws EA, Bruno MJ. et al. Survival in bile duct injury patients after laparoscopic cholecystectomy: a multidisciplinary approach of gastroenterologists, radiologists, and surgeons. Surgery 2007; 142: 1-9
• 144 de Reuver PR, Grossmann I, Busch OR. et al. Referral pattern and timing of repair are risk factors for complications after reconstructive surgery for bile duct injury. Ann Surg 2007; 245: 763-770
• 145 Ejaz A, Spolverato G, Kim Y. et al. Long-term health-related quality of life after iatrogenic bile duct injury repair. J Am Coll Surg 2014; 219: 923-932
• 146 Eikermann M, Siegel R, Broeders I. et al. Prevention and treatment of bile duct injuries during laparoscopic cholecystectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2012; 26: 3003-3039
• 147 Ford JA, Soop M, Du J. et al. Systematic review of intraoperative cholangiography in cholecystectomy. Br J Surg 2012; 99: 160-167
• 148 Giger U, Ouaissi M, Schmitz SF. et al. Bile duct injury and use of cholangiography during laparoscopic cholecystectomy. Br J Surg 2011; 98: 391-396
• 149 Landman MP, Feurer ID, Moore DE. et al. The long-term effect of bile duct injuries on health-related quality of life: a meta-analysis. HPB (Oxford) 2013; 15: 252-259
• 150 Pitt HA, Sherman S, Johnson MS. et al. Improved outcomes of bile duct injuries in the 21st century. Ann Surg 2013; 258: 490-499
• 151 Sahajpal AK, Chow SC, Dixon E. et al. Bile duct injuries associated with laparoscopic cholecystectomy: timing of repair and long-term outcomes. Arch Surg 2010; 145: 757-763
• 152 Sheffield KM, Riall TS, Han Y. et al. Association between cholecystectomy with vs without intraoperative cholangiography and risk of common duct injury. JAMA 2013; 310: 812-820
• 153 Tornqvist B, Stromberg C, Persson G. et al. Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: population based cohort study. BMJ 2012; 345: e6457
• 154 Walsh RM, Henderson JM, Vogt DP. et al. Long-term outcome of biliary reconstruction for bile duct injuries from laparoscopic cholecystectomies. Surgery 2007; 142: 450-456
• 155 Kilic A, Sheer A, Shah AS. et al. Outcomes of cholecystectomy in US heart transplant recipients. Ann Surg 2013; 258: 312-317
• 156 Sarkio S, Salmela K, Kyllonen L. et al. Complications of gallstone disease in kidney transplantation patients. Nephrol Dial Transplant 2007; 22: 886-890
• 157 Alexakis N, Connor S. Meta-analysis of one- vs. two-stage laparoscopic/endoscopic management of common bile duct stones. HPB (Oxford) 2012; 14: 254-259
• 158 Clayton ES, Connor S, Alexakis N. et al. Meta-analysis of endoscopy and surgery versus surgery alone for common bile duct stones with the gallbladder in situ. Br J Surg 2006; 93: 1185-1191
• 159 Bansal VK, Misra MC, Garg P. et al. A prospective randomized trial comparing two-stage versus single-stage management of patients with gallstone disease and common bile duct stones. Surg Endosc 2010; 24: 1986-1989
• 160 Bansal VK, Misra MC, Rajan K. et al. Single-stage laparoscopic common bile duct exploration and cholecystectomy versus two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with concomitant gallbladder stones and common bile duct stones: a randomized controlled trial. Surg Endosc 2014; 28: 875-885
• 161 Dasari BV, Tan CJ, Gurusamy KS. et al. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev 2013; 12: CD003327
• 162 Ding G, Cai W, Qin M. Single-stage vs. two-stage management for concomitant gallstones and common bile duct stones: a prospective randomized trial with long-term follow-up. J Gastrointest Surg 2014; 18: 947-951
• 163 ElGeidie AA, ElShobary MM, Naeem YM. Laparoscopic exploration versus intraoperative endoscopic sphincterotomy for common bile duct stones: a prospective randomized trial. Dig Surg 2011; 28: 424-431
• 164 ElGeidie AA, ElEbidy GK, Naeem YM. Preoperative versus intraoperative endoscopic sphincterotomy for management of common bile duct stones. Surg Endosc 2011; 25: 1230-1237
• 165 Gurusamy K, Sahay SJ, Burroughs AK. et al. Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg 2011; 98: 908-916
• 166 Wang B, Guo Z, Liu Z. et al. Preoperative versus intraoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones: system review and meta-analysis. Surg Endosc 2013; 27: 2454-2465
• 167 Koc B, Karahan S, Adas G. et al. Comparison of laparoscopic common bile duct exploration and endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy for choledocholithiasis: a prospective randomized study. Am J Surg 2013; 206: 457-463
• 168 Noble H, Tranter S, Chesworth T. et al. A randomized, clinical trial to compare endoscopic sphincterotomy and subsequent laparoscopic cholecystectomy with primary laparoscopic bile duct exploration during cholecystectomy in higher risk patients with choledocholithiasis. J Laparoendosc Adv Surg Tech A 2009; 19: 713-720
• 169 Rogers SJ, Cello JP, Horn JK. et al. Prospective randomized trial of LC+LCBDE vs ERCP/S+LC for common bile duct stone disease. Arch Surg 2010; 145: 28-33
• 170 Lu J, Cheng Y, Xiong XZ. et al. Two-stage vs single-stage management for concomitant gallstones and common bile duct stones. World J Gastroenterol 2012; 18: 3156-3166
• 171 McAlister VC, Davenport E, Renouf E. Cholecystectomy deferral in patients with endoscopic sphincterotomy. Cochrane Database Syst Rev 2007; 4: CD006233
• 172 Reinders JS, Goud A, Timmer R. et al. Early laparoscopic cholecystectomy improves outcomes after endoscopic sphincterotomy for choledochocystolithiasis. Gastroenterology 2010; 138: 2315-2320
• 173 Aboulian A, Chan T, Yaghoubian A. et al. Early cholecystectomy safely decreases hospital stay in patients with mild gallstone pancreatitis: a randomized prospective study. Ann Surg 2010; 251: 615-619
• 174 van Baal MC, Besselink MG, Bakker OJ. et al. Timing of cholecystectomy after mild biliary pancreatitis: a systematic review. Ann Surg 2012; 255: 860-866
• 175 Petrov MS, van Santvoort HC, Besselink MG. et al. Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials. Ann Surg 2008; 247: 250-257
• 176 van Santvoort HC, Besselink MG, de Vries AC. et al. Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study. Ann Surg 2009; 250: 68-75
• 177 Tse F, Yuan Y. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitis. Cochrane Database Syst Rev 2012; 5: CD009779
• 178 Sharaiha RZ, Khan MA, Kamal F. et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc 2017; 85: 904-914
• 179 Khan MA, Akbar A, Baron TH. et al. Endoscopic ultrasound-guided biliary drainage: a systematic review and meta-analysis. Dig Dis Sci 2016; 61: 684-703
• 180 Gurusamy KS, Rossi M, Davidson BR. Percutaneous cholecystostomy for high-risk surgical patients with acute calculous cholecystitis. Cochrane Database Syst Rev 2013; 8: CD007088
• 181 Winbladh A, Gullstrand P, Svanvik J. et al. Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford) 2009; 11: 183-193
• 182 Khan MA, Atiq O, Kubiliun N. et al. Efficacy and safety of endoscopic gallbladder drainage in acute cholecystitis: Is it better than percutaneous gallbladder drainage?. Gastrointest Endosc 2017; 85: 76-87 e73
• 183 Date RS, Kaushal M, Ramesh A. A review of the management of gallstone disease and its complications in pregnancy. Am J Surg 2008; 196: 599-608
• 184 Dhupar R, Smaldone GM, Hamad GG. Is there a benefit to delaying cholecystectomy for symptomatic gallbladder disease during pregnancy?. Surg Endosc 2010; 24: 108-112
• 185 Othman MO, Stone E, Hashimi M. et al. Conservative management of cholelithiasis and its complications in pregnancy is associated with recurrent symptoms and more emergency department visits. Gastrointest Endosc 2012; 76: 564-569
• 186 Barthelsson C, Anderberg B, Ramel S. et al. Outpatient versus inpatient laparoscopic cholecystectomy: a prospective randomized study of symptom occurrence, symptom distress and general state of health during the first post-operative week. J Eval Clin Pract 2008; 14: 577-584
• 187 Vaughan J, Gurusamy KS, Davidson BR. Day-surgery versus overnight stay surgery for laparoscopic cholecystectomy. Cochrane Database Syst Rev 2013; 7: CD006798